California Pharmacy & Compounding Center

Form 483 issued October 17, 2014 · Newport Beach, California

Inspection
Oct 14 – Oct 17, 2014
Observations
3
Pages
3
FEI number
3004600090

In short: On October 17, 2014, FDA issued a Form 483 with 3 observations to California Pharmacy & Compounding Center in Newport Beach, California (FEI 3004600090) after an inspection that ran Oct 14 – Oct 17, 2014. The investigators were Ademola O. Daramola, Binh T. Nguyen and Liming Zhang. Most observations concern quality system and packaging & labeling; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

2 of 3 observations on this 483 concern quality system.

Quality system2
Packaging & labeling1

Most cited: 21 CFR 211.192 (2×) · 211.125(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    Written records of investigations into the failure of a batch or any of its components to…

  3. 03

    Strict control is not exercised over labeling issued for use in…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at California Pharmacy & Compounding Center?

FDA listed 3 observations on this Form 483, mostly about quality system and packaging & labeling. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected California Pharmacy & Compounding Center?

Ademola O. Daramola, Binh T. Nguyen and Liming Zhang are named on this Form 483, for the inspection of Oct 14 – Oct 17, 2014. Each investigator has a profile showing what they cite most.

When was California Pharmacy & Compounding Center inspected by FDA?

The inspection ran Oct 14 – Oct 17, 2014, and the Form 483 is dated October 17, 2014.

How do I get the full Form 483 for California Pharmacy & Compounding Center?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free